Product Code: GVR-4-68040-641-7
U.S. Topical Cyanoacrylates Market Trends:
The U.S. topical cyanoacrylates market size was estimated at USD 31.65 million in 2024 and is expected to grow at a CAGR of 5.10% from 2025 to 2033. The market growth is attributed to the increasing demand for fast-acting, non-invasive wound closure solutions in both clinical and home care settings. These adhesives are widely used as an alternative to sutures and staples for closing surgical incisions, lacerations, and minor cuts, offering advantages such as reduced procedure time, minimal scarring, and lower infection risk. Growth is further supported by the rising number of surgical procedures, trauma cases, and sports injuries, alongside an aging population that requires more chronic wound care.
There is a growing demand for non-invasive wound closure methods, especially in outpatient clinics and emergency care settings. Topical cyanoacrylate adhesives are becoming a preferred option due to their quick application, ability to minimize scarring, and lower risk of infection compared to traditional sutures or staples. These benefits make them an attractive solution for patients and healthcare providers seeking efficient and safe alternatives for wound management.
The increasing volume of surgical procedures-ranging from cosmetic to trauma-related interventions-is driving demand for fast, reliable wound closure solutions. Topical cyanoacrylate adhesives offer a convenient and effective alternative to traditional sutures and staples, supporting quicker recovery times and enhancing patient comfort. Their ease of use aligns well with the shift toward outpatient care, where efficiency and reduced procedural complexity are key priorities.
U.S. Topical Cyanoacrylates Market Report Segmentation
This report forecasts revenue growth at the country level and provides an analysis of the latest trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the U.S. topical cyanoacrylates market report based on product, application, and end use:
- Product Outlook (Revenue USD Million, 2021 - 2033)
- 2-Octyl Cyanoacrylate
- n-Butyl-cyanoacrylate
- Application Outlook (Revenue USD Million, 2021 - 2033)
- General Surgery
- Plastic Surgery and Aesthetic Procedures
- Orthopedic
- Pediatric
- Gynecology
- Dental Surgery
- Others
- End Use Outlook (Revenue USD Million, 2021 - 2033)
- Hospitals
- Outpatient Clinics
- Home Care Settings
- Others
Table of Contents
Chapter 1. Methodology and Scope
- 1.1. Market Segmentation & Scope
- 1.2. Research Methodology
- 1.3. Information Procurement
- 1.3.1. Purchased database.
- 1.3.2. GVR's internal database
- 1.3.3. Secondary sources
- 1.3.4. Third Party Perspective
- 1.3.5. Primary research
- 1.3.6. Details of primary research
- 1.4. Information or Data Analysis
- 1.4.1. Data analysis models
- 1.5. Market Formulation & Validation
- 1.6. Model Details
- 1.6.1. Commodity flow analysis (Model 1)
- 1.6.1.1. Approach 1: Commodity flow approach
- 1.6.2. Volume price analysis (Model 2)
- 1.6.2.1. Approach 2: Volume price analysis
- 1.7. List of Secondary Sources
- 1.8. List of Primary Sources
- 1.9. List of Abbreviations
Chapter 2. Executive Summary
- 2.1. Market Outlook
- 2.2. Segment Outlook
- 2.3. Competitive Insights Outlook
Chapter 3. U.S. Topical Cyanoacrylates Market Variables, Trends & Scope
- 3.1. Market Lineage Outlook
- 3.1.1. Related/ancillary market outlook.
- 3.2. User Perspective Analysis
- 3.2.1. Consumer behavior analysis
- 3.3. Market Dynamics
- 3.3.1. Market driver analysis
- 3.3.1.1. Rising demand for minimally invasive procedures
- 3.3.1.2. Growth in surgical volume
- 3.3.1.3. Regulatory approvals and product innovations
- 3.3.2. Market restraint analysis
- 3.3.2.1. Limited use in high-tension wounds
- 3.3.2.2. Potential for allergic reactions or dermatitis
- 3.3.3. Market opportunity analysis
- 3.3.4. Market challenge analysis
- 3.4. U.S. Topical Cyanoacrylates Market Analysis Tools
- 3.4.1. Industry Analysis - Porter's
- 3.4.1.1. Supplier power
- 3.4.1.2. Buyer power
- 3.4.1.3. Substitution threat
- 3.4.1.4. Threat of new entrant
- 3.4.1.5. Competitive rivalry
- 3.4.2. PESTEL Analysis
- 3.4.2.1. Political landscape
- 3.4.2.2. Technological landscape
- 3.4.2.3. Economic landscape
Chapter 4. U.S. Topical Cyanoacrylates Market: Product Estimates & Trend Analysis
- 4.1. Definitions and Scope
- 4.2. Product Market Share, 2021 & 2033
- 4.3. Segment Dashboard
- 4.4. U.S. Topical Cyanoacrylates Market by Product Outlook
- 4.5. Market Size & Forecasts and Trend Analyses, 2024 to 2030 for the following
- 4.5.1. 2-Octyl Cyanoacrylate
- 4.5.1.1. 2-Octyl cyanoacrylate market revenue estimates and forecasts, 2021 - 2033 (USD Million)
- 4.5.2. n-Butyl-Cyanoacrylate
- 4.5.2.1. n-Butyl-cyanoacrylate market revenue estimates and forecasts, 2021 - 2033 (USD Million)
Chapter 5. U.S. Topical Cyanoacrylates Market: Application Estimates & Trend Analysis
- 5.1. Definitions and Scope
- 5.2. Application Market Share, 2021 & 2033
- 5.3. Segment Dashboard
- 5.4. U.S. Topical Cyanoacrylates Market by Application Outlook
- 5.5. Market Size & Forecasts and Trend Analyses, 2024 to 2030 for the following
- 5.5.1. General Surgery
- 5.5.1.1. General surgery market estimates and forecast 2021 to 2033 (USD Million)
- 5.5.2. Plastic Surgery and Aesthetic Procedures
- 5.5.2.1. Plastic surgery and aesthetic procedures market estimates and forecast 2021 to 2033 (USD Million)
- 5.5.3. Orthopedic
- 5.5.3.1. Orthopedic market estimates and forecast 2021 to 2033 (USD Million)
- 5.5.4. Pediatric
- 5.5.4.1. Pediatric market estimates and forecast 2021 to 2033 (USD Million)
- 5.5.5. Gynecology
- 5.5.5.1. Gynecology market estimates and forecast 2021 to 2033 (USD Million)
- 5.5.6. Dental Surgery
- 5.5.6.1. Dental surgery market estimates and forecast 2021 to 2033 (USD Million)
- 5.5.7. Others
- 5.5.7.1. Others market estimates and forecast 2021 to 2033 (USD Million)
Chapter 6. U.S. Topical Cyanoacrylates Market: End Use Estimates & Trend Analysis
- 6.1. Definitions and Scope
- 6.2. End Use Market Share, 2021 & 2033
- 6.3. Segment Dashboard
- 6.4. U.S. Topical Cyanoacrylates Market by End Use Outlook
- 6.5. Market Size & Forecasts and Trend Analyses, 2024 to 2030 for the following
- 6.5.1. Hospitals
- 6.5.1.1. Hospitals market estimates and forecast 2021 to 2033 (USD Million)
- 6.5.2. Outpatient Clinics
- 6.5.2.1. Outpatient clinics market estimates and forecast 2021 to 2033 (USD Million)
- 6.5.3. Home Care Setting
- 6.5.3.1. Home care settings market estimates and forecast 2021 to 2033 (USD Million)
- 6.5.4. Others
- 6.5.4.1. Others market estimates and forecast 2021 to 2033 (USD Million)
Chapter 7. Competitive Landscape
- 7.1. Recent Developments & Impact Analysis, By Key Market Participants
- 7.2. Company/Competition Categorization
- 7.3. Vendor Landscape
- 7.3.1. List of key distributors and channel partners
- 7.3.2. Key customers
- 7.3.3. Key company market share analysis, 2024
- 7.3.4. Ethicon, Inc. (Johnson & Johnson)
- 7.3.4.1. Company overview
- 7.3.4.2. Financial performance
- 7.3.4.3. Product benchmarking
- 7.3.4.4. Strategic initiatives
- 7.3.5. 3M
- 7.3.5.1. Company overview
- 7.3.5.2. Financial performance
- 7.3.5.3. Product benchmarking
- 7.3.5.4. Strategic initiatives
- 7.3.6. B. Braun SE
- 7.3.6.1. Company overview
- 7.3.6.2. Financial performance
- 7.3.6.3. Product benchmarking
- 7.3.6.4. Strategic initiatives
- 7.3.7. Chemence Medical, Inc.
- 7.3.7.1. Company overview
- 7.3.7.2. Financial performance
- 7.3.7.3. Product benchmarking
- 7.3.7.4. Strategic initiatives
- 7.3.8. H.B. Fuller Medical Adhesive Technologies, LLC
- 7.3.8.1. Company overview
- 7.3.8.2. Financial performance
- 7.3.8.3. Product benchmarking
- 7.3.8.4. Strategic initiatives
- 7.3.9. GluStitch, Inc.
- 7.3.9.1. Company overview
- 7.3.9.2. Financial performance
- 7.3.9.3. Product benchmarking
- 7.3.9.4. Strategic initiatives
- 7.3.10. Medline Industries
- 7.3.10.1. Company overview
- 7.3.10.2. Financial performance
- 7.3.10.3. Product benchmarking
- 7.3.10.4. Strategic initiatives
- 7.3.11. Advanced Medical Solutions
- 7.3.11.1. Company overview
- 7.3.11.2. Financial performance
- 7.3.11.3. Product benchmarking
- 7.3.11.4. Strategic initiatives
- 7.3.12. Cardinal Health
- 7.3.12.1. Company overview
- 7.3.12.2. Financial performance
- 7.3.12.3. Product benchmarking
- 7.3.12.4. Strategic initiatives
- 7.3.13. Meyer Haake
- 7.3.13.1. Company overview
- 7.3.13.2. Financial performance
- 7.3.13.3. Product benchmarking
- 7.3.13.4. Strategic initiatives